1800 202 8726
Targeted therapy

Is Imatinib — Actually Chemotherapy?

Many people call any cancer medicine 'chemo'. Imatinib is not chemotherapy. It is a targeted therapy — a daily tablet that blocks a single protein driving your cancer — and that difference matters for which side effects to watch for and which advice to follow.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • Not chemotherapy — Imatinib belongs to a class called tyrosine kinase inhibitors. It works nothing like chemotherapy drugs.
  • A specific target — It blocks BCR-ABL, an abnormal protein found in nearly all CML cases, rather than attacking all dividing cells.
  • Different side effects — Hair loss and severe immune suppression are not typical. Muscle cramps, mild nausea, and eye swelling are more common.
  • Often long-term — For most people with CML, imatinib is taken daily for years, and often for life.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Imatinib (Glivec) is not chemotherapy. It is a targeted therapy — a tablet taken daily that blocks a single abnormal protein, BCR-ABL, that drives CML. The side effects, monitoring schedule, and treatment duration are all different from chemotherapy. Reading chemotherapy advice while on imatinib can send you in the wrong direction.

How is imatinib different from chemotherapy?

FeatureChemotherapyImatinib (Glivec)
What it isDrugs that kill rapidly dividing cellsA tablet that blocks one abnormal protein, BCR-ABL
How it worksAttacks all fast-dividing cells — cancerous and healthySwitches off the specific signal telling CML cells to divide
How you take itInfusion or tablets in cycles, with rest periods betweenOne tablet daily, without treatment breaks
Hair lossCommon with many regimensUncommon
NauseaOften significantMild to moderate; usually manageable
Immune suppressionSignificant — raises infection riskMild; does not suppress immunity the same way
Treatment durationDefined course — weeks to monthsOften years, sometimes lifelong
MonitoringBlood tests around treatment cyclesRegular blood counts and BCR-ABL PCR tests

What is imatinib and how does it work?

Chemotherapy drugs kill cells that divide rapidly — which is why they also affect hair follicles, the gut lining, and bone marrow. Imatinib works nothing like that.

In CML, an abnormality called the Philadelphia chromosome creates a faulty protein called BCR-ABL. That protein sends a constant signal telling cancer cells to divide. Imatinib locks on to BCR-ABL and switches that signal off.

Because it targets one protein rather than all dividing cells, side effects typical of chemotherapy — hair loss, severe nausea, heavy immune suppression — are not expected with imatinib.

What does taking imatinib every day actually involve?

You take imatinib as a tablet, every day, usually with food. There are no infusion appointments, no treatment cycles, and no scheduled rest weeks.

Your team tracks your response with regular blood tests, including a BCR-ABL PCR test that measures how much of the abnormal signal remains detectable. Reaching a sustained deep molecular response over time is the aim.

Side effects are most common in the first few weeks. Mild nausea, muscle cramps, and ankle or eye swelling are most frequent. Tell your team about anything persistent — adjustments usually help — rather than stopping the medicine.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What do these words on your report mean?

BCR-ABL
The abnormal protein that drives CML. It forms when two genes that should never be joined — BCR and ABL — fuse together. Imatinib targets this protein directly.
Philadelphia chromosome
The chromosomal abnormality that creates BCR-ABL. Found in nearly all CML cases, it is what makes CML treatable with drugs like imatinib.
Tyrosine kinase inhibitor (TKI)
The class of drug imatinib belongs to. TKIs block specific signalling proteins inside cancer cells rather than attacking all dividing cells. Imatinib was the first widely approved TKI.
Molecular response
How much BCR-ABL remains detectable in your blood. Major molecular response (MMR) and deep molecular response (DMR) are the milestones your team aims for over time.
BCR-ABL PCR
The blood test used to measure BCR-ABL levels over time. It tracks whether imatinib is working and guides all decisions about continuing or changing treatment.

What should you tell your team while on imatinib?

  • Tell your team every medicine, supplement, or herbal product you take — several interact with imatinib.
  • Take imatinib with food or a large glass of water to reduce nausea.
  • Do not stop or skip doses without asking your oncologist first.
  • Keep every scheduled blood test, including the PCR test — these guide all treatment decisions.
  • Report muscle cramps, persistent nausea, unusual swelling, or any bleeding that does not stop quickly.
  • Tell any other doctor or dentist treating you that you are on a targeted therapy, not chemotherapy.

What is it like to take imatinib for years?

Will I be on this tablet for the rest of my life?

Many people with CML do take imatinib lifelong. However, patients who sustain a deep molecular response over many years may be assessed for treatment-free remission — a carefully supervised attempt to stop, with close monitoring for any return of disease. Whether this applies to you depends on your response history and other factors your oncologist will evaluate. Stopping without medical supervision is dangerous. Never discontinue on your own.

Is generic imatinib the same as Glivec?

Yes. Generic imatinib contains the same active molecule as Glivec and must meet the same regulatory standards set by CDSCO. Generic versions have made treatment significantly more affordable across India without changing how the medicine works. If you switch between branded and generic, tell your oncologist so your response monitoring stays consistent.

What if imatinib stops working?

Imatinib can occasionally lose effectiveness, usually because cancer cells develop a mutation that makes them resistant to it. Your PCR tests are designed to detect this early, before you notice any change in how you feel. There are later-generation tyrosine kinase inhibitors — including nilotinib and dasatinib — that work differently and can often regain control. Your oncologist will explain the next step if this becomes relevant.

Can I miss a dose?

One missed dose is unlikely to cause harm. Take your next dose at the usual time and do not double it. What matters is long-term consistency — repeated missed doses can allow cancer cells to develop resistance. If remembering is a problem, tell your team rather than managing alone. Pill organisers or phone reminders are easy to put in place and worth doing.

Can I work and carry on with daily life?

Most people continue working and living normally on imatinib. Early side effects — nausea, tiredness, muscle cramps — often improve after the first few weeks as your body adjusts. If a side effect is affecting your daily life, tell your oncologist before considering stopping. Dose adjustments or medicines to manage specific symptoms can make a significant difference.

Should I follow chemotherapy diet advice while on imatinib?

No. Chemotherapy dietary restrictions do not apply to imatinib. Imatinib does interact with grapefruit and grapefruit juice — both should be avoided. Ask your team for dietary guidance specific to your treatment rather than following chemotherapy advice found online or offered by well-meaning friends. The two treatments are not the same thing.

Explore 95 more Understanding Chemotherapy, Myths & Trials topics

HUB — Chemotherapy Myths and Alternative Treatment Claims

HUB — What Is Chemotherapy and Why Has It Been Advised?

All Understanding Chemotherapy, Myths & Trials →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is Glivec the same as imatinib?

Yes. Glivec is the brand name; imatinib is the active molecule inside it. Generic imatinib is widely available in India and contains the same medicine to the same regulatory standard. Your oncologist or pharmacist can confirm whether your prescription is branded or generic.

What are the main side effects of imatinib?

The most common are mild nausea, muscle cramps, fatigue, and swelling around the eyes or ankles, particularly in the first weeks. Hair loss and severe immune suppression — typical of many chemotherapy regimens — are not common with imatinib. Side effects usually improve after the first month. Tell your team about anything persistent rather than stopping the medicine.

How will I know if imatinib is working?

Through regular BCR-ABL PCR blood tests that measure how much of the abnormal signal remains detectable. The aim is to reach a major or deep molecular response over time. You may feel completely well throughout — which is why the tests, not symptoms, are the measure of response. Keep every appointment even when you feel fine.

Can I eat normally while on imatinib?

Broadly yes, with one exception: grapefruit and grapefruit juice can raise imatinib levels in your blood and should be avoided. Take imatinib with food to reduce nausea. Ask your team for specific guidance, rather than following dietary restrictions written for chemotherapy — they do not apply.

Is imatinib only used for CML?

No. Imatinib is also used for some forms of acute lymphoblastic leukaemia and gastrointestinal stromal tumour (GIST), among others. The principle is the same — blocking a specific protein driving the cancer. Your oncologist will explain the reason it has been prescribed for you.

What is the difference between a TKI and chemotherapy?

Chemotherapy attacks all rapidly dividing cells — cancerous and healthy — which is why it affects hair, the gut lining, and bone marrow. Tyrosine kinase inhibitors like imatinib block a specific protein that cancer cells depend on. The side effects, monitoring schedule, and what counts as a response are all different. Chemotherapy advice does not apply to imatinib.

Full index

Browse all 579 chemotherapy topics

Every page in this section, grouped by the part of treatment it belongs to. Open a group to see what is in it.

Before You Start: Tests, Ports & Fertility42
Blood Counts, Infection, Fever & Emergencies73

Anaemia & Low Haemoglobin

HUB — Low Blood Counts, Infection and Fever During Chemotherapy

Chemotherapy and Supportive Medicines by Name75

Chemotherapy Drugs by Name

HUB — Chemotherapy Drugs by Name

HUB — Generic, Branded and Biosimilar Chemotherapy in India

HUB — Supportive Medicines Used With Chemotherapy

Chemotherapy at CION Cancer Clinics1
Chemotherapy by Cancer Type and Special Situations5

Special Populations & Comorbidities

HUB — Chemotherapy in Special Situations

Chemotherapy in Hyderabad: Cost, Centres & Access93

HUB — Choosing a Chemotherapy Centre and Safe Administration

Common Side Effects and How They Are Managed78
Food, Diet, Hydration & Household Safety6
How Chemotherapy Is Given: Regimens, Cycles & Infusion Days85

Other Ways Chemotherapy Is Given

HUB — Cycles, Schedules and What Happens on Infusion Day

Is It Working, Finishing Chemotherapy & Survivorship7

Is It Working? Response & Scans

HUB — Is Chemotherapy Working? Scans and Response

HUB — When Chemotherapy Stops Working

Nerve, Skin, Heart, Kidney and Cognitive Effects5

Skin, Nails & Hand-Foot Syndrome

Heart, Lung & Organ Toxicity

HUB — Effects on the Heart, Kidneys, Liver and Nerves

Understanding Chemotherapy, Myths & Trials97

HUB — Chemotherapy Myths and Alternative Treatment Claims

HUB — Clinical Trials in Cancer Treatment

HUB — What Is Chemotherapy and Why Has It Been Advised?

Work, Family, Relationships and Emotional Support12
Call now Book free consultation